Case number IPR2025-00949
AZURITY PHARMACEUTICALS, INC. v. Helsinn Healthcare S.A. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Sep 4, 2025 | 2070 | patent_owner | Exhibit 2070 Download |
| Sep 4, 2025 | 2066 | patent_owner | Exhibit 2066 Download |
| Sep 4, 2025 | 2065 | patent_owner | Exhibit 2065 Download |
| Sep 4, 2025 | 2064 | patent_owner | Exhibit 2064 Download |
| Sep 4, 2025 | 2063 | patent_owner | Exhibit 2063 Download |
| Sep 4, 2025 | 2062 | patent_owner | Exhibit 2062 Download |
| Sep 4, 2025 | 2061 | patent_owner | Exhibit 2061 Download |
| Sep 4, 2025 | 2060 | patent_owner | Exhibit 2060 Download |
| Sep 4, 2025 | 2059 | patent_owner | Exhibit 2059 Download |
| Sep 4, 2025 | 2058 | patent_owner | Exhibit 2058 Download |
| Sep 4, 2025 | 2057 | patent_owner | Exhibit 2057 Download |
| Sep 4, 2025 | 2056 | patent_owner | Exhibit 2056 Download |
| Sep 4, 2025 | 2055 | patent_owner | Exhibit 2055 Download |
| Sep 4, 2025 | 2054 | patent_owner | Exhibit 2054 Download |
| Sep 4, 2025 | 2053 | patent_owner | Exhibit 2053 Download |
| Sep 4, 2025 | 2052 | patent_owner | Exhibit 2052 Download |
| Sep 4, 2025 | 2051 | patent_owner | Exhibit 2051 Download |
| Sep 4, 2025 | 2050 | patent_owner | Exhibit 2050 Download |
| Sep 4, 2025 | 2049 | patent_owner | Exhibit 2049 Download |
| Sep 4, 2025 | 2048 | patent_owner | Exhibit 2048 Download |
| Sep 4, 2025 | 2047 | patent_owner | Exhibit 2047 Download |
| Sep 4, 2025 | 2046 | patent_owner | Exhibit 2046 Download |
| Sep 4, 2025 | 2045 | patent_owner | Exhibit 2045 Download |
| Sep 4, 2025 | 2044 | patent_owner | Exhibit 2044 Download |
| Sep 4, 2025 | 2043 | patent_owner | Exhibit 2043 Download |
| Sep 4, 2025 | 2042 | patent_owner | Exhibit 2042 Download |
| Sep 4, 2025 | 2039 | patent_owner | Exhibit 2039 Download |
| Sep 4, 2025 | 2037 | patent_owner | Exhibit 2037 Download |
| Sep 4, 2025 | 2036 | patent_owner | Exhibit 2036 Download |
| Aug 4, 2025 | 2035 | patent_owner | Exhibit 2035 Download |
| Aug 4, 2025 | 2034 | patent_owner | Exhibit 2034 Download |
| Aug 4, 2025 | 2033 | patent_owner | Exhibit 2033 Download |
| Aug 4, 2025 | 2032 | patent_owner | Exhibit 2032 Download |
| Aug 4, 2025 | 2031 | patent_owner | Exhibit 2031 Download |
| Aug 4, 2025 | 2030 | patent_owner | Exhibit 2030 Download |
| Aug 4, 2025 | 2029 | patent_owner | Exhibit 2029 Download |
| Aug 4, 2025 | 2028 | patent_owner | Exhibit 2028 Download |
| Aug 4, 2025 | 2027 | patent_owner | Exhibit 2027 Download |
| Aug 4, 2025 | 2026 | patent_owner | Exhibit 2026 Download |
| Aug 4, 2025 | 2025 | patent_owner | Exhibit 2025 Download |
| Aug 4, 2025 | 2024 | patent_owner | Exhibit 2024 Download |
| Aug 4, 2025 | 2023 | patent_owner | Exhibit 2023 Download |
| Aug 4, 2025 | 2022 | patent_owner | Exhibit 2022 Download |
| Aug 4, 2025 | 2021 | patent_owner | Exhibit 2021 Download |
| Aug 4, 2025 | 2020 | patent_owner | Exhibit 2020 Download |
| Aug 4, 2025 | 2019 | patent_owner | Exhibit 2019 Download |
| Aug 4, 2025 | 2018 | patent_owner | Exhibit 2018 Download |
| Aug 4, 2025 | 2017 | patent_owner | Exhibit 2017 Download |
| Aug 4, 2025 | 2016 | patent_owner | Exhibit 2016 Download |
| Aug 4, 2025 | 2015 | patent_owner | Exhibit 2015 Download |
| Aug 4, 2025 | 2014 | patent_owner | Exhibit 2014 Download |
| Aug 4, 2025 | 2013 | patent_owner | Exhibit 2013 Download |
| Aug 4, 2025 | 2012 | patent_owner | Exhibit 2012 Download |
| Aug 4, 2025 | 2011 | patent_owner | Exhibit 2011 Download |
| Aug 4, 2025 | 2010 | patent_owner | Exhibit 2010 Download |
| Aug 4, 2025 | 2009 | patent_owner | Exhibit 2009 Download |
| Aug 4, 2025 | 2008 | patent_owner | Exhibit 2008 Download |
| Aug 4, 2025 | 2007 | patent_owner | Exhibit 2007 Download |
| Aug 4, 2025 | 2006 | patent_owner | Exhibit 2006 Download |
| Aug 4, 2025 | 2005 | patent_owner | Exhibit 2005 Download |
| Aug 4, 2025 | 2004 | patent_owner | Exhibit 2004 Download |
| Aug 4, 2025 | 2003 | patent_owner | Exhibit 2003 Download |
| Aug 4, 2025 | 2002 | patent_owner | Exhibit 2002 Download |
| Aug 4, 2025 | 2001 | patent_owner | Exhibit 2001 Download |
| May 1, 2025 | 1061 | petitioner | B. Cromie, Drug Combinations, 1(2) Current Medical Research and Opinion Download |
| May 1, 2025 | 1060 | petitioner | G. Sanso, Double capsule for the administration of active principles Download |
| May 1, 2025 | 1059 | petitioner | P. Li & L. Zhao, Developing Early Formulations: Practice and Perspective Download |
| May 1, 2025 | 1058 | petitioner | Drugs@FDA: FDA-Approved Drugs Download |
| May 1, 2025 | 1057 | petitioner | Provisional Patent Appl. 61/262,470, filed 18 November 2009 Download |
| May 1, 2025 | 1056 | petitioner | Provisional Patent Appl. 61/382,709, filed 14 September 2010 Download |
| May 1, 2025 | 1055 | petitioner | PCT Publication WO 2011/061622, filed 18 November 2010 Download |
| May 1, 2025 | 1054 | petitioner | DailyMed excerpts relating to Aloxi (palonosetron HCl) Capsules Download |
| May 1, 2025 | 1053 | petitioner | DailyMed excerpts relating to ALOXI (palonosetron HCl) Capsules Download |
| May 1, 2025 | 1052 | petitioner | RxList, ALOXI (palonosetron HCl) Capsules Download |
| May 1, 2025 | 1051 | petitioner | NK1 receptor antagonist by Roche, Advances in Drug Discovery Download |
| May 1, 2025 | 1050 | petitioner | Parenteral, Merriam-Webster Download |
| May 1, 2025 | 1049 | petitioner | S.F. Zhou, Drugs Behave as Substrates, Inhibitors and Inducers of Human Download |
| May 1, 2025 | 1048 | petitioner | W. Yeo et al., A randomized study of aprepitant, ondansetron Download |
| May 1, 2025 | 1047 | petitioner | D.S. Wang, Effect of aprepitant for the prevention of chemotherapy-induced Download |
| May 1, 2025 | 1046 | petitioner | K.E. Thummel, Gut instincts: CYP3A4 and intestinal drug metabolism, 117(11) Download |
| May 1, 2025 | 1045 | petitioner | A.G. Thomas, Netupitant and palonosetron trigger NK1 receptor Download |
| May 1, 2025 | 1044 | petitioner | Ronald D. Schoenwald, Pharmacokinetics in Drug Discovery and Development Download |
| May 1, 2025 | 1043 | petitioner | R. Saito et al., Roles of substance P and NK1 receptor in the brainstem Download |
| May 1, 2025 | 1042 | petitioner | C. Ruhlmann & J. Herrstedt, Casopitant: a novel NK1-receptor antagonist Download |
| May 1, 2025 | 1041 | petitioner | C. Rojas, The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits Download |
| May 1, 2025 | 1040 | petitioner | T. Qiu et al., Antiemetic regimen with aprepitant in the prevention Download |
| May 1, 2025 | 1039 | petitioner | S. Poli-Bigelli et al., Addition of the neurokinin 1 receptor antagonist Download |
| May 1, 2025 | 1038 | petitioner | G.S. Paulekuhn et al., Trends in active pharmaceutical ingredient salt Download |
| May 1, 2025 | 1037 | petitioner | P.J. Hesketh et al., The Oral Neurokinin-1 Antagonist Aprepitant Download |
| May 1, 2025 | 1036 | petitioner | Press Release, GSK provides update on regulatory filings for Zunrisa Download |
| May 1, 2025 | 1035 | petitioner | S.M. Grunberg et al., Effectiveness of a single-day three-drug regimen Download |
| May 1, 2025 | 1034 | petitioner | D.G. Warr et al., Efficacy and tolerability of aprepitant Download |
| May 1, 2025 | 1033 | petitioner | U.S. Food and Drug Administration, Q3A Impurities in New Drug Substances Download |
| May 1, 2025 | 1032 | petitioner | U.S. Food and Drug Administration, General Considerations for the Clinical Download |
| May 1, 2025 | 1031 | petitioner | DailyMed, EMEND (aprepitant) Capsule Download |
| May 1, 2025 | 1030 | petitioner | Merck & Co., EMEND, package insert (2008) Download |
| May 1, 2025 | 1029 | petitioner | Download |
| May 1, 2025 | 1028 | petitioner | R.A. Duffy, Potential therapeutic targets for neurokinin-1 receptor Download |
| May 1, 2025 | 1027 | petitioner | A. De Leon, Palonosetron (Aloxi): a second-generation 5-HT3 Download |
| May 1, 2025 | 1026 | petitioner | S.P. Chawla et al., Establishing the Dose of the Oral NK1 Antagonist Download |
| May 1, 2025 | 1025 | petitioner | S.P. Chawla et al., Establishing the Dose of the Oral NK1 Antagonist Download |
| May 1, 2025 | 1024 | petitioner | A.E. Chang et al., eds., Oncology: An Evidence-Based Approach (2006) Download |
| May 1, 2025 | 1023 | petitioner | D. Campos et al., Prevention of cisplatin-induced emesis Download |
| May 1, 2025 | 1022 | petitioner | M.S. Aapro et al., A phase III, double-blind, randomized trial Download |
| May 1, 2025 | 1021 | petitioner | G.K. Reddy et al., Novel Neurokinin-1 Antagonists as Antiemetics Download |
| May 1, 2025 | 1020 | petitioner | Curriculum Vitae of Dr. Stephen J. Peroutka Download |
| May 1, 2025 | 1019 | petitioner | K. Jordan et al., Guidelines for Antiemetic Treatment of Chemotherapy Download |
| May 1, 2025 | 1018 | petitioner | R.J. Gralla et al., Recommendations for the use of antiemetics Download |
| May 1, 2025 | 1017 | petitioner | D. Bonadeo et al., Soft Capsules Comprising Palonosetron Hydrochloride Download |
| May 1, 2025 | 1016 | petitioner | J.D. Herrington et al., Randomized, Placebo-controlled Download |
| May 1, 2025 | 1015 | petitioner | Eisai, Inc., ALOXI (palonosetron HCl) Capsules, package insert (Aug. 2008) Download |
| May 1, 2025 | 1014 | petitioner | Download |
| May 1, 2025 | 1013 | petitioner | The Antiemetic Subcommittee of the Multinational Association of Supportive Download |
| May 1, 2025 | 1012 | petitioner | R. Hargreaves, Imaging Substance P Receptors (NK1) Download |
| May 1, 2025 | 1011 | petitioner | T. Hoffmann et al., Design and synthesis of a novel Download |
| May 1, 2025 | 1010 | petitioner | J. Herrstedt & P. Dombernowsky, Anti-Emetic Therapy in Cancer Chemotherapy Download |
| May 1, 2025 | 1009 | petitioner | Expert Declaration of Dr. Stephen J. Peroutka Download |
| May 1, 2025 | 1008 | petitioner | Prosecution history for U.S. Appl. 15/923,050, filed 16 March 2018 Download |
| May 1, 2025 | 1007 | petitioner | Prosecution history for U.S. Appl. 15/003,327, filed 19 May 2016, Pt1 Download |
| May 1, 2025 | 1007 | petitioner | Prosecution history for U.S. Appl. 15/003,327, filed 19 May 2016, Pt2 Download |
| May 1, 2025 | 1006 | petitioner | Prosecution history for U.S. Appl. 14/069,927, filed 01 November 2013 Download |
| May 1, 2025 | 1005 | petitioner | Prosecution history for U.S. Appl. 13/077,462, filed 31 March 2011, Pt1 Download |
| May 1, 2025 | 1005 | petitioner | Prosecution history for U.S. Appl. 13/077,462, filed 31 March 2011, Pt2 Download |
| May 1, 2025 | 1004 | petitioner | U.S. Patent 10,828,297 B2, issued 10 November 2020 Download |
| May 1, 2025 | 1003 | petitioner | U.S. Patent 9,943,515 B2, issued 17 April 2018 Download |
| May 1, 2025 | 1002 | petitioner | U.S. Patent 9,186,357 B2, issued 17 November 2015 Download |
| May 1, 2025 | 1001 | petitioner | U.S. Patent 8,623,826 B2, issued 17 January 2014 Download |
| Dec 4, 2025 | 16 | petitioner | Petitioner's Objections to Evidence Download |
| Dec 4, 2025 | 15 | patent_owner | Patent Owner's Objections to Evidence Download |
| Nov 20, 2025 | 14 | board | Notice: Errata Download |
| Nov 19, 2025 | 13 | board | Scheduling Order Download |
| Nov 19, 2025 | 12 | board | Decision Granting Institution of Inter Partes Review Download |
| Sep 19, 2025 | 11 | board | Director Discretionary Decision: Refer Download |
| Sep 4, 2025 | 10 | patent_owner | Patent Owner's Preliminary Response Download |
| Sep 4, 2025 | 9 | patent_owner | Patent Owner's Current List of Exhibits Download |
| Sep 4, 2025 | 8 | petitioner | Petitioner's Opposition to Patent Owner's Discretionary Denial Request Download |
| Aug 4, 2025 | 7 | patent_owner | Patent Owner's Brief Requesting Discretionary Denial of Institution Download |
| Aug 4, 2025 | 6 | patent_owner | Patent Owner's Current List of Exhibits Download |
| Jun 4, 2025 | 5 | board | Notice: Notice filing date accorded Download |
| May 22, 2025 | 4 | patent_owner | Patent Owner's Mandatory Notices Download |
| May 22, 2025 | 3 | patent_owner | Power of Attorney for Patent Owner Helsinn Healthcare S.A. Download |
| May 1, 2025 | 2 | petitioner | Petition: as filed Download |
| May 1, 2025 | 1 | petitioner | Notice: Power of Attorney Download |
